Navigating the ebbs and flows, highs and lows of diabetes during pregnancy
New National GDM Guideline - are we there yet?
Summary of the new guideline, the process and implementation strategies.
Obstetrician at Counties Manukau with a special interest in diabetes in pregnancy, preterm birth and perinatal mortality in South Asian women. Heena was part of the core team involved in writing the new guideline. She is passionate about reducing health inequity and identifying and addressing barriers to care that face women who live in bigger bodies, migrants and those facing economic and social challenges.
Managing diabetes distress
Diabetes distress is commonly experienced by people living with diabetes and it can impact on the way diabetes is managed. This talk will give practical tips for recognising diabetes distress, and what to do about it.
Lisa Hoyle is a consultant health psychologist working in diabetes, diabetes and pregnancy, and renal services at Counties Manukau District - Te Whatu Ora. She is a member of the New Zealand Society for the Study of Diabetes Executive Committee and has held various leadership roles in her time at Counties.
Lisa is dedicated to providing mana-enhancing care and reducing inequities.
GLP-1 Inhibitors and pregnancy
The good, the bad, and the missing evidence. What are the benefits and risks of GLP-1 agonists before, during and after pregnancy?
Stephanie attended the University of Auckland and completed dual specialist physician training in General Medicine and Endocrinology at Rotorua, Christchurch and Waikato Hospitals before returning to Auckland to complete a fellowship in Obstetric Medicine at National Women’s Health. She was awarded the SOMANZ Certificate of Obstetric Medicine in 2016.
Stephanie is Clinical Lead for the Diabetes in Pregnancy Service and is an experienced Obstetric Physician who is passionate about helping patients and their whānau plan and achieve healthy pregnancies. She also works part time as a General Medicine Physician at Auckland City Hospital.
Continuous glucose monitoring: the good, the bad, and the future
Continuous glucose monitoring (CGM) has transformed care for people living with Type 1 diabetes, but does that success translate to pregnancy and to all populations? This talk explores the benefits, limitations, and where to next for CGM technology in pregnancy.
Charlotte’s research centres on equity and rethinking how we provide maternity care for those with pregnancy complications. In 2025 she led a feasibility study on continuous glucose monitoring (CGM) for type 2 diabetes in pregnancy and a scoping review of inclusion of indigenous people / persons of colour in antenatal CGM research.